newsexercisemen
Unlocking the Benefits of Squats for Male Sexual Health
By MedXY|Oct 1, 2025
Explore the scientific principles and practical strategies of using squats to boost male sexual health, supported by research and expert insights.
Urology
Latest news
Clinical UpdatesEnzalutamidemCRPC
PARP inhibitors shine: How the TALAPRO-2 trial is changing the landscape of prostate cancer with precision medicine
By MedXY|Oct 1, 2025
Treatment for advanced prostate cancer has advanced significantly in the past decade, but metastatic castration-resistant…
Clinical Updatesadverse eventsclinical trial
Testosterone Therapy in Middle-Aged and Older Men with Hypogonadism: Balancing Clinical Benefits and Risks
By MedXY|Oct 1, 2025
Testosterone therapy offers modest benefits for sexual function, anemia, and bone health in older men with hypogonadism, but increases risks of venous thromboembolism, fractures, and arrhythmias. Careful patient selection and individualized
newsGynecologyPelvic Inflammatory Disease
Symptoms of Pelvic Inflammatory Disease: The Three Most Distinctive Signs
By MedXY|Oct 1, 2025
Pelvic inflammatory disease (PID) commonly presents with lower abdominal pain, abnormal vaginal discharge, and systemic symptoms like fever. Early recognition and treatment are vital to prevent complications.
newsBenign prostatic hyperplasialower urinary tract symptoms
Serenoa repens (Saw Palmetto) in Benign Prostatic Hyperplasia: Clinical Evidence and Implications for Practice
By MedXY|Oct 1, 2025
Recent high-quality evidence indicates that Serenoa repens provides little to no benefit for lower urinary tract symptoms due to benign prostatic enlargement compared to placebo.
newscalciumhealth
Can Kidney Stone Sufferers Safely Take Calcium Supplements? Unveiling the Truth
By MedXY|Oct 1, 2025
Exploring the relationship between calcium intake and kidney stones, this article provides evidence-based guidance for patients and health professionals.
Clinical Updateschemotherapyenfortumab vedotin
Enfortumab Vedotin Plus Pembrolizumab vs Chemotherapy in Untreated Locally Advanced or Metastatic Urothelial Cancer: Patient-Reported Outcomes from the EV-302 Phase 3 Study
By MedXY|Oct 1, 2025
The EV-302 trial shows enfortumab vedotin plus pembrolizumab improves survival and quality of life over platinum-based chemotherapy in untreated advanced urothelial cancer patients.
Clinical Updatesprostate cancerRadiotherapy
Early Toxicity Comparison of Moderately Hypofractionated Radiotherapy and Stereotactic Body Radiotherapy in Prostate Cancer: Insights from the PACE-C Trial
By MedXY|Oct 1, 2025
The PACE-C phase 3 trial shows that stereotactic body radiotherapy (SBRT) and moderately hypofractionated radiotherapy (MHRT) have comparable early toxicity profiles in intermediate- and high-risk prostate cancer patients.
Clinical Updatesatezolizumabcabozantinib
Cabozantinib Plus Atezolizumab in mCRPC: CONTACT-02 Phase 3 Final Results and Clinical Implications
By MedXY|Oct 1, 2025
The CONTACT-02 phase 3 trial shows cabozantinib plus atezolizumab improves progression-free survival but not overall survival in advanced mCRPC post-ARPI, offering a novel non-androgen receptor-based option.
Clinical Updatesantimicrobial stewardshiprandomized trial
Individualised Versus Standard 10-Day Antibiotic Therapy in Pediatric Febrile UTI: Insights from the INDI-UTI Trial
By MedXY|Oct 1, 2025
A Danish multicentre trial found individualised, shorter antibiotic regimens for febrile pediatric UTIs reduce overall antibiotic exposure and adverse events, but with a modestly higher recurrence risk compared to standard 10-day treatment.
Clinical UpdatesAntimicrobial ResistanceDoxycycline
Doxycycline Post-Exposure Prophylaxis Significantly Reduces Bacterial STIs Among MSM and Transgender Women: Final Results from the DoxyPEP Trial
By MedXY|Oct 1, 2025
The DoxyPEP trial demonstrates that doxycycline post-exposure prophylaxis markedly lowers bacterial STI incidence in men who have sex with men and transgender women, with good tolerability and minimal resistance over 12 months.
Clinical Updatesandrogen deprivation therapyclinical trial
Metformin in Prostate Cancer: Revisiting Hopes and Realities After Recent Phase 3 Trials
By MedXY|Oct 1, 2025
Recent large RCTs show metformin does not improve survival or reduce metabolic syndrome risk in prostate cancer patients on ADT, though it modestly improves metabolic parameters.
Clinical Updatesmetastatic prostate cancerPSMA
First-in-Human Results of Terbium-161 PSMA Radioligand Therapy in mCRPC: Insights from the VIOLET Study
By MedXY|Oct 1, 2025
A phase 1/2 trial demonstrates the safety of [161Tb]Tb-PSMA-I&T, a novel dual beta-Auger radioligand, in heavily pretreated metastatic castration-resistant prostate cancer patients, supporting further clinical investigation.
newspatient experienceurology
How to Make Urology Care More Comfortable for Women
By MedXY|Sep 30, 2025
Exploring why women often feel discomfort during urology visits and actionable strategies to create a more welcoming, effective clinical experience.
news
Understanding and Preventing Prostatitis: What Every Man Should Know and Do
By MedXY|Sep 30, 2025
Prostatitis is common and often misunderstood. Learn the latest science, dispel myths, and discover practical steps to keep your prostate healthy.
Family Medicine & Nutritionlifestylelongevity
Does More Sex Mean a Longer Life? The Surprising Science Behind Sexual Activity and Longevity
By MedXY|Sep 30, 2025
Exploring whether more frequent sex truly leads to a longer life, this article examines scientific evidence, dispels myths, and offers practical sexual wellness advice for couples.
Family Medicine & Nutritionmen's healthsexual health
When Sex Ends Without Ejaculation: Understanding Ejaculatory Dysfunction
By MedXY|Dec 25, 2025
Persistent inability to ejaculate during sex may indicate ejaculatory dysfunction, a common but often misunderstood men’s health issue. This article explores causes, myths, and practical steps for care.
newsmen's healthsubtyping
Treating Chronic Prostatitis: Why Subtyping Matters for Effective Care
By MedXY|Sep 30, 2025
Chronic prostatitis is complex and requires tailored treatment based on its specific subtype. Learn why accurate diagnosis is key for better outcomes.
newsmen's healthprevention
Guarding the ‘Life Gland’: What Every Man Should Know About Prostate Health
By MedXY|Dec 25, 2025
Explore the vital role of the prostate, common misconceptions, science-backed practices, and expert insights to safeguard men’s health at every age.
newsadolescent healthendocrine disorders
From Boyhood to Manhood: Recognizing and Addressing Pubertal Developmental Disorders
By MedXY|Dec 25, 2025
Explore the science, warning signs, and practical advice on abnormal male puberty, bridging knowledge for families and clinicians.
Browse by specialty
Open language-specific specialty feeds and department pages.